 |
|||||
|
|||||
|
Dear Subscriber,
Today's Top Stories: Friday- February 20, 2009
ZACKS RANK BUY STOCKS
Learn how to profit from our exclusive Zacks Rank stock-ranking system with free resources. Read More...
Sponsor
Bold Dividend Strategy Pays Out a Whopping 33.1% This fund is an investor's dream. It's paid the same monthly dividend since its inception, and thanks to the recent market meltdown it now yields 33.1%. Not only does it pay fat dividends, but it offers double-digit capital appreciation potential to boot. And this isn't the only investment we've found with this combination of large dividends and growth potential. See where we found high-yielders paying 14.9%, 20.2%, and 22.4%. Go Here for these Dividend Superstars: BEST OF ZACKS EQUITY RESEARCH
PERSONAL FINANCE: provided by Kiplinger.com
EDUCATION: Momentum.
OTHER ZACKS RESOURCES:
Manage your Profit from the Pros subscription: REFER-A-FRIEND
If you enjoy this e-mail newsletter, then please pass it along to a friend. Simply forward them the link below to sign up for their own free subscription. THANKS! Regards and Happy Investing,
Charles Rotblut, CFA p.s. What is the mission for Zacks Profit from the Pros? To find out how we will help you become a more successful investor, click here. |
|||||
|
Visit /performance for information about the performance numbers displayed in this newsletter. Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security. To contact us by mail:
Zacks Investment Research
To unsubscribe from receiving "Zacks.com Profit from the Pros" |
|||||
- Latest News
- Most Popular
- 3 Top-Ranked Consumer ETFs to Buy Now
- This Week's Top Value Stocks
- RTI: When Will We Finally See a Pullback?
- RTI: When is the Fed's "Taper Telegraph" Coming?
- Insurance Industry Stock Outlook - May 2013
- Top Stocks with Big Potential Catch-Up Moves
- Roundtable Top Picks of the Week
- Anatomy of Success: Green Mountain Coffee
- The Mega-Rally Rolls On
- Biotechnology ETF Investing 101
- AWS 5/21: The Beginning of the End for QE
Recent Quotes
| No Recent Quote currently available |
My Portfolio
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks #1 Stocks on the Move 05/21/2013
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.